While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

The official made the remarks on Tuesday, addressing the 4th International Conference and Exhibition on Iranian Medical Biotech Products and Related Industries (Iran Bio) being held from February 4 to ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...

banking on improved demand for its products and services used in developing therapies. However, some life sciences firms such as Danaher have indicated smaller biotech clients are still cautious ...

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

BIS issued an Interim Final Rule that amends the Export Administration Regulation (EAR) to address dual use export ...